Renal Sympathetic Denervation System via Intraluminal Ultrasonic Ablation: Therapeutic Intravascular Ultrasound Design and Preclinical Evaluation

Purpose: To assess the safety and performance of a nonfocused and nonballooned ultrasonic (US) catheter based renal sympathetic denervation (RDN) system in normotensive swine. Materials and Methods: RDN with the therapeutic intravascular US catheter was evaluated in 3 experiments: (1) therapeutic intravascular US RDN vsl a control group of untreated animals, with follow-up of 30, 45, and 90 days (n = 6; n = 12 renal arteries for each group); (h) therapeutic intravascular US RDN, vs radiofrequency (RF) RDN in the contralateral artery in the same animal (n = 2; n = 4 renal arteries); and (iii) therapeutic intravascular US RDN in a recently stent-implanted renal artery (n = 2; n = 4 renal arteries). Results: In the first experiment, therapeutic intravascular US-RDN was safe, without angiographic evidence of dissection or renal artery stenosis. Neuronal tissue vacuolization, nuclei pyknosis, and perineuronal inflammation were evident after RDN, without renal artery wall damage. Norepinephrine levels were significantly lower after therapeutic intravascular US RDN after 30, 45, and 90 days compared with the control group (200.17 pg/mg +/- 63.35, 184.75 pg/mg +/- 44.51, and 203.43 pg/mg +/- 58.54, respectively, vs 342.42 pg/mg +/- 79.97). In the second experiment, deeper neuronal ablation penetrance was found with therapeutic intravascular US RDN vs RF RDN (maximal penetrance from endothelium of 7.0 mm vs 3.5 mm, respectively). There was less damage to the artery wall after therapeutic intravascular US RDN than with RF RDN, after which edema and injured endothelium were seen. In the third experiment, denervation inside the stent-implanted segments was feasible without damage to the renal artery wall or stent. Conclusions: The therapeutic intravascular US system performed safely and reduced norepinephrine levels. Deeper penetrance and better preservation of vessel wall were observed with therapeutic intravascular US RDN vs RF RDN2 Neuronal ablations were observed in stent-implanted renal arteries.